Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

79.90USD
20 Apr 2018
Change (% chg)

$-0.10 (-0.12%)
Prev Close
$80.00
Open
$80.10
Day's High
$80.49
Day's Low
$79.48
Volume
1,437,585
Avg. Vol
1,343,373
52-wk High
$89.71
52-wk Low
$76.42

Latest Key Developments (Source: Significant Developments)

Medtronic Expands Visualase MRI-Guided Laser Ablation System to Europe with CE Mark Approval
Tuesday, 10 Apr 2018 10:00am EDT 

April 10 (Reuters) - Medtronic PLC ::MEDTRONIC EXPANDS VISUALASE(TM) MRI-GUIDED LASER ABLATION SYSTEM TO EUROPEAN MARKETS WITH CE MARK APPROVAL.MEDTRONIC PLC - CE MARK & EUROPEAN LAUNCH OF VISUALASE MRI-GUIDED LASER ABLATION SYSTEM.  Full Article

Medtronic To Redeem About $1.2 Bln Of Medtronic Inc's Senior Notes
Friday, 23 Mar 2018 05:41pm EDT 

March 23 (Reuters) - Medtronic Plc ::MEDTRONIC PLC - INTENDS TO REDEEM ABOUT $1.2 BILLION OF MEDTRONIC, INC.'S SENIOR NOTES - SEC FILING.MEDTRONIC - NOTES TO BE REDEEMED INCLUDE ALL $400.0 MILLION AMOUNT OF 5.600% SENIOR NOTES DUE 2019 & $765.6 MILLION AMOUNT OF 4.450% SENIOR NOTES DUE 2020.  Full Article

Medtronic, Lehigh Valley Health Network To Deliver Healthcare Programs For LVHN Patients
Wednesday, 28 Feb 2018 10:45am EST 

Feb 28 (Reuters) - Medtronic PLC ::MEDTRONIC AND LEHIGH VALLEY HEALTH NETWORK SIGN STRATEGIC PARTNERSHIP AGREEMENT FOCUSED ON DELIVERING VALUE-BASED HEALTHCARE PROGRAMS.MEDTRONIC - ‍ANNOUNCED 5-YEAR PARTNERSHIP AIMED TO IMPROVE HEALTHCARE OUTCOMES FOR PATIENTS SERVED BY LVHN​.MEDTRONIC PLC - INITIAL HEALTHCARE PROGRAMS UNDER AGREEMENT WILL ADDRESS CONDITIONS SUCH AS CARDIOVASCULAR DISEASE, STROKE, AND LUNG CANCER.  Full Article

Medtronic Launches First 2 mm Drug-Eluting Stent In U.S.
Monday, 26 Feb 2018 09:00am EST 

Feb 26 (Reuters) - Medtronic Plc ::MEDTRONIC LAUNCHES FIRST 2.0 MM DRUG-ELUTING STENT IN UNITED STATES DESIGNED TO TREAT PATIENTS WITH SMALL VESSELS.MEDTRONIC PLC - ANNOUNCED U.S. FDA APPROVAL AND U.S. LAUNCH OF RESOLUTE ONYX 2.0 MM DRUG-ELUTING STENT.  Full Article

Medtronic Receives FDA Approval For New Arm Indication For Guardian Sensor 3
Monday, 26 Feb 2018 08:00am EST 

Feb 26 (Reuters) - Medtronic Plc ::MEDTRONIC RECEIVES FDA APPROVAL FOR NEW ARM INDICATION FOR GUARDIAN(TM) SENSOR 3 - FURTHER ENHANCING THE MINIMED(TM) 670G HYBRID CLOSED LOOP EXPERIENCE.  Full Article

Medtronic Receives FDA Clearance For Riptide Aspiration System
Tuesday, 16 Jan 2018 10:01am EST 

Jan 16 (Reuters) - Medtronic Plc ::MEDTRONIC RECEIVES FDA CLEARANCE FOR RIPTIDE(TM) ASPIRATION SYSTEM.MEDTRONIC SAYS UNIT RECEIVED U.S. FDA CLEARANCE OF RIPTIDE ASPIRATION SYSTEM.  Full Article

FDA Approves Innovative Clinician Programmer For The Medtronic Synchromed II Intrathecal Drug Delivery System
Wednesday, 10 Jan 2018 07:00am EST 

Jan 10 (Reuters) - Medtronic Plc ::FDA APPROVES INNOVATIVE CLINICIAN PROGRAMMER FOR THE MEDTRONIC SYNCHROMED II INTRATHECAL DRUG DELIVERY SYSTEM FOR CHRONIC PAIN AND SEVERE SPASTICITY.  Full Article

Medtronic reports Q2 non-GAAP earnings per share of $1.07
Tuesday, 21 Nov 2017 06:45am EST 

Nov 21 (Reuters) - Medtronic Plc :Medtronic reports second quarter financial results.Q2 non-GAAP earnings per share $1.07.Q2 GAAP earnings per share $1.48.Q2 earnings per share view $0.98 -- Thomson Reuters I/B/E/S.Medtronic Plc - ‍company reiterates full year revenue and EPS guidance​.Medtronic Plc - qtrly ‍revenue of $7.1 billion​.Q2 revenue view $6.93 billion -- Thomson Reuters I/B/E/S.Medtronic plc qtrly ‍CVG worldwide revenue of $2.773 billion increased 7 percent on both a reported and constant currency basis​.Medtronic plc qtrly ‍RTG worldwide revenue of $1.863 billion increased 2 percent on both a reported and constant currency basis​.FY2018 earnings per share view $4.68, revenue view $29.36 billion -- Thomson Reuters I/B/E/S.Medtronic Plc qtrly ‍spine revenue of $659 million decreased 1 percent on both a reported and constant currency basis​.Medtronic Plc - ‍in fiscal year 2018, company continues to expect comparable, constant currency revenue growth to be in range of 4 to 5 percent​.Medtronic Plc - "‍Hurricane Maria, in particular, significantly affected our manufacturing operations in Puerto Rico"​ for quarter.  Full Article

Medtronic announces FDA approval and U.S. launch of next generation pacemakers
Monday, 20 Nov 2017 09:00am EST 

Nov 20 (Reuters) - Medtronic Plc :Medtronic announces FDA approval and U.S. launch of next generation pacemakers.Medtronic Plc - announces ‍U.S. FDA approval and U.S. commercial launch of portfolio of Azure pacemakers with Bluesync technology​.  Full Article

Medtronic ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​
Wednesday, 8 Nov 2017 04:45pm EST 

Nov 8 (Reuters) - Medtronic Plc :Medtronic announces preliminary second quarter revenue.Medtronic PLC - ‍reiterates Q2 EPS expectations excluding Hurricane Maria impact​.Medtronic PLC - ‍preliminary Q2 revenue of approximately $7.1 billion​.Medtronic PLC - ‍company announced that impact of hurricane maria was approximately $55 to $65 million to its q2 revenue​.Medtronic - preliminary ‍Q2 revenue increased 3 percent on comparable, constant currency basis.Medtronic PLC - ‍impact of hurricane maria expected to be approximately $0.03 to its q2 non-gaap earnings per share​.Medtronic - ‍excluding impact of hurricane maria, prelim. Q2 revenue growth would have been 4 percent on comparable, constant currency basis​.Medtronic PLC - expects a one cent positive impact to Q2 adjusted EPS from foreign currency​.Q2 earnings per share view $0.94, revenue view $6.87 billion -- Thomson Reuters I/B/E/S.  Full Article

BRIEF-Medtronic Announces U.S. Launch Of Optisphere Embolization Spheres

* MEDTRONIC - ANNOUNCES U.S. LAUNCH OF OPTISPHERE EMBOLIZATION SPHERES, A RESORBABLE EMBOLIC PLATFORM DESIGNED FOR EMBOLIZATION OF HYPERVASCULAR TUMORS Source text for Eikon: Further company coverage: